100 related articles for article (PubMed ID: 33040175)
1. Presence of the aldehyde dehydrogenase 2 variant ALDH2*2 considerably increases EC
Ushijima K; Ogami C; Tsuji Y; Nagano T; Fujimura A
Eur J Clin Pharmacol; 2021 Mar; 77(3):431-433. PubMed ID: 33040175
[No Abstract] [Full Text] [Related]
2. Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.
Nagano T; Ushijima K; Taga N; Takeuchi M; Kawada MA; Aizawa K; Imai Y; Fujimura A
Eur J Clin Pharmacol; 2019 Oct; 75(10):1361-1367. PubMed ID: 31250045
[TBL] [Abstract][Full Text] [Related]
3. Role of Mitochondrial Aldehyde Dehydrogenase in Nitroglycerin-Mediated Vasodilation: Observations Concerning the Dose-Response Relationship.
He JD; Lytvyn Y; Zhou K; Parker JD
J Cardiovasc Pharmacol; 2019 Jun; 73(6):359-364. PubMed ID: 31162244
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory effect of nitroglycerin in Japanese subjects with different aldehyde dehydrogenase 2 (ALDH2) genotypes.
Miura T; Nishinaka T; Terada T; Yonezawa K
Chem Biol Interact; 2017 Oct; 276():40-45. PubMed ID: 28342890
[TBL] [Abstract][Full Text] [Related]
5. East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina.
Mizuno Y; Harada E; Kugimiya F; Shono M; Kusumegi I; Yoshimura M; Kinoshita K; Yasue H
Circ J; 2020 Feb; 84(3):479-486. PubMed ID: 32009064
[TBL] [Abstract][Full Text] [Related]
6. Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is Necessary and Sufficient for Vascular Bioactivation of Nitroglycerin.
Opelt M; Eroglu E; Waldeck-Weiermair M; Russwurm M; Koesling D; Malli R; Graier WF; Fassett JT; Schrammel A; Mayer B
J Biol Chem; 2016 Nov; 291(46):24076-24084. PubMed ID: 27679490
[TBL] [Abstract][Full Text] [Related]
7. Transdermal kinetics and nitrate tolerance. Measurements of vasodilation by photoplethysmography.
Klemsdal TO
Scand Cardiovasc J; 1997; 31(6):368. PubMed ID: 9455788
[No Abstract] [Full Text] [Related]
8. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin.
Li Y; Zhang D; Jin W; Shao C; Yan P; Xu C; Sheng H; Liu Y; Yu J; Xie Y; Zhao Y; Lu D; Nebert DW; Harrison DC; Huang W; Jin L
J Clin Invest; 2006 Feb; 116(2):506-11. PubMed ID: 16440063
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins.
Huellner MW; Schrepfer S; Weyand M; Weiner H; Wimplinger I; Eschenhagen T; Rau T
FASEB J; 2008 Jul; 22(7):2561-8. PubMed ID: 18272654
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase-independent bioactivation of nitroglycerin in porcine and bovine blood vessels.
Neubauer R; Wölkart G; Opelt M; Schwarzenegger C; Hofinger M; Neubauer A; Kollau A; Schmidt K; Schrammel A; Mayer B
Biochem Pharmacol; 2015 Feb; 93(4):440-8. PubMed ID: 25576686
[TBL] [Abstract][Full Text] [Related]
11. Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2.
Beretta M; Wölkart G; Schernthaner M; Griesberger M; Neubauer R; Schmidt K; Sacherer M; Heinzel FR; Kohlwein SD; Mayer B
Circ Res; 2012 Feb; 110(3):385-93. PubMed ID: 22207712
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between aldehyde dehydrogenase-2 gene polymorphisms and efficacy of nitroglycerin].
Zhang H; Chen YG; Xu F; Xue L; Jiang CX; Zhang Y
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):629-32. PubMed ID: 17967228
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans.
Mackenzie IS; Maki-Petaja KM; McEniery CM; Bao YP; Wallace SM; Cheriyan J; Monteith S; Brown MJ; Wilkinson IB
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1891-5. PubMed ID: 16051882
[TBL] [Abstract][Full Text] [Related]
14. [Is Antabus therapy connected with reduced efficacy of nitroglycerin?].
Skovenborg E
Ugeskr Laeger; 2006 Apr; 168(17):1670; author reply 1670-1. PubMed ID: 16674895
[No Abstract] [Full Text] [Related]
15. Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humans.
Hubacek JA; Jirsa M; Bobak M; Pelclova D; Zakharov S
Clin Genet; 2018 Nov; 94(5):445-449. PubMed ID: 29968299
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of nitroglycerin--a new piece in the puzzle.
Mayer B
Angew Chem Int Ed Engl; 2003 Jan; 42(4):388-91. PubMed ID: 12569502
[No Abstract] [Full Text] [Related]
17. Warm air convection heating blankets may increase the absorption of transdermal nitroglycerin.
Roth JV
Anesthesiology; 1997 May; 86(5):1208-9. PubMed ID: 9158370
[No Abstract] [Full Text] [Related]
18. Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP).
Peng LM; Chen XP; Sun J; Guo YJ; Li L; Mo L; Xie W; Li YJ; Yang TL; Li CC
Int J Clin Pharmacol Ther; 2012 Oct; 50(10):701-11. PubMed ID: 22909898
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment.
Kim J; Chen CH; Yang J; Mochly-Rosen D
J Biomed Sci; 2017 May; 24(1):33. PubMed ID: 28532411
[TBL] [Abstract][Full Text] [Related]
20. Strategies for Avoiding Benzopyrone Hepatotoxicity in Lymphedema Management-The Role of Pharmacogenetics, Metabolic Enzyme Gene Identification, and Patient Selection.
Hu M; Piller NB
Lymphat Res Biol; 2017 Dec; 15(4):317-323. PubMed ID: 29087786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
